InsidersTradesSigma
Track the 普洛药业 share price and the full management transaction log of the company, a publicly traded company based in China. Shares trade on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 普洛药业 has published 2 insider filings. Market capitalisation: €23bn. The latest transaction was disclosed on 25 April 2023 (Sale). Among the most active insiders: 何春. The full history is free.
2
Insider Decl.
n/a
Thresholds
€196,592
1 ops.
Buy Volume
€15,757
1 ops.
Sell Volume
11Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 11,613 of 29,064 companies
56.8
score / 100
Value52
Quality61
FCF yld3.6%
Earn yld3.9%
EV/EBITDA14.0x
ROE13%
Gross mgn26%
Net mgn9.1%
Debt/EBITDA0.9x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 25 April 2023
关于 普洛药业
普洛药业是一家在XSHE市场上市的健康和制药公司。它专注于创新药物的研发和生产。